250 related articles for article (PubMed ID: 16789836)
1. Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response.
Walters KA; Joyce MA; Thompson JC; Smith MW; Yeh MM; Proll S; Zhu LF; Gao TJ; Kneteman NM; Tyrrell DL; Katze MG
PLoS Pathog; 2006 Jun; 2(6):e59. PubMed ID: 16789836
[TBL] [Abstract][Full Text] [Related]
2. HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.
Joyce MA; Walters KA; Lamb SE; Yeh MM; Zhu LF; Kneteman N; Doyle JS; Katze MG; Tyrrell DL
PLoS Pathog; 2009 Feb; 5(2):e1000291. PubMed ID: 19242562
[TBL] [Abstract][Full Text] [Related]
3. Chimeric mouse model for the infection of hepatitis B and C viruses.
Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
5. A novel cDNA-uPA/SCID/Rag2
Uchida T; Teraoka Y; Imamura M; Abe-Chayama H; Makokha GN; Hayes CN; Aikata H; Hamamura S; Ishida Y; Tateno C; Shirouzu T; Kawai S; Tanaka Y; Ohdan H; Okada S; Chayama K
J Viral Hepat; 2023 Mar; 30(3):262-272. PubMed ID: 36575861
[TBL] [Abstract][Full Text] [Related]
6. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
7. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
Ohshita H; Tateno C
Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
[TBL] [Abstract][Full Text] [Related]
8. Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation.
Colasanti O; Burm R; Huang HE; Riedl T; Traut J; Gillich N; Li TF; Corneillie L; Faure-Dupuy S; Grünvogel O; Heide D; Lee JY; Tran CS; Merle U; Chironna M; Vondran FFW; Esser-Nobis K; Binder M; Bartenschlager R; Heikenwälder M; Meuleman P; Lohmann V
J Hepatol; 2023 Sep; 79(3):645-656. PubMed ID: 37121436
[TBL] [Abstract][Full Text] [Related]
9. Mice with Chimeric Human Livers and Their Applications.
Douglas DN; Kneteman NM
Methods Mol Biol; 2019; 1911():459-479. PubMed ID: 30593646
[TBL] [Abstract][Full Text] [Related]
10. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
[TBL] [Abstract][Full Text] [Related]
12. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
[TBL] [Abstract][Full Text] [Related]
13. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
Lupberger J; Croonenborghs T; Roca Suarez AA; Van Renne N; Jühling F; Oudot MA; Virzì A; Bandiera S; Jamey C; Meszaros G; Brumaru D; Mukherji A; Durand SC; Heydmann L; Verrier ER; El Saghire H; Hamdane N; Bartenschlager R; Fereshetian S; Ramberger E; Sinha R; Nabian M; Everaert C; Jovanovic M; Mertins P; Carr SA; Chayama K; Dali-Youcef N; Ricci R; Bardeesy NM; Fujiwara N; Gevaert O; Zeisel MB; Hoshida Y; Pochet N; Baumert TF
Gastroenterology; 2019 Aug; 157(2):537-551.e9. PubMed ID: 30978357
[TBL] [Abstract][Full Text] [Related]
14. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
[TBL] [Abstract][Full Text] [Related]
15. Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.
Tateno C; Kawase Y; Tobita Y; Hamamura S; Ohshita H; Yokomichi H; Sanada H; Kakuni M; Shiota A; Kojima Y; Ishida Y; Shitara H; Wada NA; Tateishi H; Sudoh M; Nagatsuka S; Jishage K; Kohara M
PLoS One; 2015; 10(11):e0142145. PubMed ID: 26536627
[TBL] [Abstract][Full Text] [Related]
16. Development of humanized mice for the study of hepatitis C virus infection.
Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
[TBL] [Abstract][Full Text] [Related]
17. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
[TBL] [Abstract][Full Text] [Related]
19. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
Meuleman P; Leroux-Roels G
Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
[TBL] [Abstract][Full Text] [Related]
20. Animal model for study of human hepatitis viruses.
Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
